Genzyme Corporation

All the email addresses for genzyme.com

{first}.{last}@genzyme.com
372 email addresses
http://wwwmsviewsandrelatednews.blogspot.com/2013/12/genzyme-receives-complete-response.html September 9, 2017
http://mscare.org/news/news.asp November 11, 2016
http://wwwmsviewsandrelatednews.blogspot.com.tr/2013_12_29_archive.html September 9, 2017
http://wwwmsviewsandrelatednews.blogspot.fr/2013 September 9, 2017
http://thestreet.com/story/12689569/1/sanofi-slowing-of-brain-atrophy-and-reductions-in-new-ms-lesions-sustained-at-three-years-in-patients-treated-with-genzymes-lemtrada.html October 10, 2016
http://biospace.com/news/fda-will-review-genzyme-corporations-lemtrada/335232 January 1, 2015
http://biospace.com/News/fda-will-review-genzyme-corporations-lemtrada/335232 May 5, 2015
http://slideshare.net/gavingiovannoni/lemtrada-fda-crl30december-2013 April 4, 2014
http://biospace.com/news/fda-turns-its-nose-up-at-genzyme-corporations/319516 January 1, 2015
http://news.genzyme.com/press-release/genzyme-receives-complete-response-letter-fda-lemtrada-alemtuzumab-application January 1, 2015
http://wwwmsviewsandrelatednews.blogspot.com/2013_12_29_archive.html August 8, 2017
http://drugs.com/nda/lemtrada_131230.html January 1, 2015
http://radaris.com/p/jack/cox January 1, 2015
http://news.sanofigenzyme.com/press-release/more-50-presentations-new-data-genzymes-multiple-sclerosis-franchise-be-featured-ectri February 2, 2017
http://news.sanofigenzyme.com/press-release/first-ms-patients-us-receive-genzymes-lemtrada-following-fda-approval February 2, 2017
http://news.sanofigenzyme.com/press-release/genzymes-lemtrada-approved-fda February 2, 2017
http://news.sanofigenzyme.com/press-release/new-analysis-suggests-aubagio-teriflunomide-slows-brain-atrophy-people-relapsing-multi February 2, 2017
http://news.genzyme.com/press-release/more-50-presentations-new-data-genzymes-multiple-sclerosis-franchise-be-featured-ectri February 2, 2016
http://mediaroom.sanofi.com/sanofi-at-four-years-treatment-effect-maintained-in-more-than-two-thirds-of-patients-who-received-genzymes-lemtrada-in-pivotal-studies-2 May 5, 2017
http://mediaroom.sanofi.com/sanofi-new-analysis-suggests-aubagio-teriflunomide-slows-brain-atrophy-in-people-with-relapsing-multiple-sclerosis-2 May 5, 2017
http://mediaroom.sanofi.com/sanofi-maintien-de-leffet-de-lemtrada-alemtuzumab-de-genzyme-pendant-quatre-ans-sur-le-ralentissement-de-latrophie-cerebrale-et-lactivite-des-lesions-visibles-a-lirm-2 May 5, 2017
http://news.genzyme.com/press-release/treatment-effects-maintained-over-five-years-majority-patients-relapsing-remitting-mul February 2, 2016
http://news.genzyme.com/press-release/new-analysis-suggests-aubagio-teriflunomide-slows-brain-atrophy-people-relapsing-multi February 2, 2016
http://mscurefund.org/genzymes-lemtrada-approved-by-the-fda March 3, 2016
http://mediaroom.sanofi.com/sanofi-lemtrada-de-genzyme-approuve-par-la-fda-2 May 5, 2017
http://mediaroom.sanofi.com/sanofi-effect-of-genzymes-multiple-sclerosis-treatment-lemtrada-alemtuzumab-on-slowing-brain-atrophy-and-mri-lesion-activity-maintained-through-four-years-2 May 5, 2017
http://news.sanofigenzyme.com/press-release/treatment-effects-maintained-over-five-years-majority-patients-relapsing-remitting-mul February 2, 2017
http://pressreleasepoint.com/data-genzyme-s-multiple-sclerosis-franchise-featured-aan January 1, 2015
http://businesswire.com/news/home/20140529006522/en/Genzyme%E2%80%99s-Lemtrada-Resubmission-Accepted-Review-FDA March 3, 2015
http://news.genzyme.com/press-release/genzyme-present-aubagio-teriflunomide-and-lemtrada-alemtuzumab-data-cmsc June 6, 2015
http://drugs.com/clinical_trials/genzyme-announces-positive-new-data-two-phase-3-studies-oral-eliglustat-tartrate-gaucher-15151.html August 8, 2017
http://biospace.com/news/genzyme-corporation-touts-positive-ph3-drug-data/287858 July 7, 2017
http://blog.rarediseases.org/genzyme-and-nord-establish-program-to-help-undiagnosed-patients-with-rare-diseases March 3, 2016
http://biospace.com/news/fda-oks-isis-pharmaceuticals-inc-genzyme/286074 January 1, 2015
http://biospace.com/news/european-commission-ec-clears-wider-use-for/281575 August 8, 2017
http://aol.com/article/2013/01/29/genzyme-and-isis-announce-fda-approval-of-kynamro-/20442674 November 11, 2016
http://drugs.com/clinical_trials/genzyme-isis-provide-update-chmp-opinion-kynamro-mipomersen-14956.html November 11, 2016
http://businesswire.com/news/home/20130129006862/en/genzyme-isis-announce-fda-approval-kynamro%E2%84%A2-mipomersen February 2, 2015
http://dailyfinance.com/2012/12/07/genzyme-receives-european-label-expansion-for-thyr January 1, 2015
http://fiercebiotech.com/press-releases/genzyme-and-isis-provide-update-chmp-opinion-kynamro-mipomersen March 3, 2016
http://news.genzyme.com/press-release/genzyme-and-nord-establish-program-help-undiagnosed-patients-rare-diseases January 1, 2015
http://aol.com/2013/01/29/genzyme-and-isis-announce-fda-approval-of-kynamro- September 9, 2017
http://businesswire.com/news/genzyme/20121207005056/en July 7, 2017
http://stage-rarediseasessite.azurewebsites.net/genzyme-and-nord-establish-program-to-help-undiagnosed-patients-with-rare-diseases August 8, 2017
http://news.genzyme.com/press-release/2012/genzyme-and-isis-provide-update-chmp-opinion-kynamro-mipomersen January 1, 2015
http://news.genzyme.com/press-release/genzyme-announces-winners-patient-advocacy-leadership-pal-awards May 5, 2015
http://clinicaspace.com/news/genzyme-corporation-touts-positive-ph3-drug-data/287858/source=yesterdaysmostpopular January 1, 2015
http://news.genzyme.com/press-release/genzyme-launches-fifth-annual-patient-advocacy-leadership-pal-awards-program February 2, 2016
http://businesswire.com/news/genzyme/20121214005287/en November 11, 2016
http://aol.com/2013/03/04/genzymes-head-of-rare-diseases-honored-by-the-gene August 8, 2017
http://mediaroom.sanofi.com/sanofi-genzyme-strengthens-endocrinology-portfolio-with-acquisition-of-rare-disease-therapy-caprelsa-vandetanib-from-astrazeneca-2 August 8, 2017
http://bdsra.org/bdsra-awarded-genzyme-patient-advocacy-leadership-pal-awards February 2, 2016
http://fiercebiotech.com/press-releases/genzyme-and-isis-announce-fda-approval-kynamrotm-mipomersen-sodium-injectio April 4, 2016
http://businesswire.com/news/home/20130129006862/en January 1, 2015
http://businesswire.com/news/home/20130215005540/en April 4, 2015
http://news.genzyme.com/press-release/genzyme-strengthens-endocrinology-portfolio-acquisition-rare-disease-therapy-caprelsa- February 2, 2016
http://mediaroom.sanofi.com/sanofi-genzyme-renforce-son-portefeuille-endocrinologie-avec-lacquisition-de-caprelsatm-vandetanib-dastrazeneca-pour-le-traitement-de-maladies-rares-2 July 7, 2017
http://clinicaspace.com/news/genzyme-corporations-mipomersen-in-trouble-in-the/282337 January 1, 2015
http://dailyfinance.com/2013/01/29/genzyme-and-isis-announce-fda-approval-of-kynamro- May 5, 2016
http://fiercebiotech.com/biotech/genzyme-and-isis-announce-fda-approval-of-kynamro-tm-mipomersen-sodium-injection-for June 6, 2017
http://ir.isispharm.com/phoenix.zhtml August 8, 2015
http://businesswire.com/news/genzyme/20120529005571/en February 2, 2015
http://biospace.com/News/genzyme-corporation-submits-drug-for-rare/254844/source=TopBreaking May 5, 2015
http://businesswire.com/news/genzyme/20120329005973/en January 1, 2015
http://businesswire.com/news/genzyme/20121126005695/en January 1, 2015
http://reuters.com/article/2012/11/26/idUS127079+26-Nov-2012+BW20121126 May 5, 2015
http://newswire.ca/fr/news-releases/genzyme-recognizes-international-rare-disease-day-with-second-annual-patient-advocacy-grant-program-509725871.html September 9, 2017
http://businesswire.com/news/genzyme/20120416006272/en January 1, 2015
http://drugs.com/nda/kynamro_121019.html February 2, 2015
http://benzinga.com/pressreleases/12/10/b3008145/fda-advisory-committee-recommends-kynamro-for-homozygous-familial-hyper January 1, 2015
http://afirma.com/physicians/latest-news/details February 2, 2016
http://drugs.com/nda/kynamro_120329.html April 4, 2015
http://news.sanofigenzyme.com/press-release/genzyme-honors-innovation-gaucher-disease-research-through-its-2012-gaucher-generation February 2, 2017
http://news.sanofigenzyme.com/press-release/2012/fda-advisory-committee-recommends-kynamro-homozygous-familial-hypercholesterolemi February 2, 2017
http://aol.com/2012/11/26/genzyme-honors-innovation-in-gaucher-disease-resea August 8, 2017
http://businesswire.com/news/genzyme/20120229005299/en April 4, 2015
http://drugs.com/clinical_trials/kynamro-mipomersen-sodium-data-presented-xvi-international-symposium-atherosclerosis-13251.html January 1, 2015
http://news.genzyme.com/press-release/genzyme-honors-innovation-gaucher-disease-research-through-its-2012-gaucher-generation February 2, 2016
http://news.genzyme.com/print/node/2850 June 6, 2016
http://news.genzyme.com/print/node/208 June 6, 2016
http://biospace.com/news/genzyme-corporation-and-isis-pharmaceuticals-inc/261712 February 2, 2015
http://aol.com/2012/10/18/fda-advisory-committee-recommends-kynamro-for-homo July 7, 2017
http://phrma.org/news-media/related-resources/member-companies April 4, 2015
http://drugs.com/nda/kynamro_120529.html February 2, 2015
http://phrma.org/codes-and-guidelines/member-company-contacts October 10, 2016
http://genzyme.cz/cs/aktuality/spolecnost-oslavila-mezinarodni-den-vzacnych-onemocneni-druhym-vyrocnim-programem-na-podporu-zajmu-pacientu-ndash-patient-advocacy-grant-program.html May 5, 2016
http://news.genzyme.com/press-release/2012/fda-advisory-committee-recommends-kynamro-homozygous-familial-hypercholesterolemi February 2, 2016
http://businesswire.com/news/genzyme/20110228005611/en April 4, 2015
http://drugs.com/news/genzyme-announces-regulatory-approvals-expanded-waterford-ireland-manufacturing-plant-37981.html January 1, 2015
http://businesswire.com/news/genzyme/20120301005875/en January 1, 2015
http://globenewswire.com/news-release/2014/01/13/601799/10063927/en/genzyme-and-alnylam-expand-collaboration-on-rare-genetic-diseases.html January 1, 2015
http://businesswire.com/news/genzyme/20110616005203/en January 1, 2015
http://drugs.com/clinical_trials/genzyme-study-myozyme-pompe-published-new-england-journal-medicine-9177.html January 1, 2015
http://finance.boston.com/boston/news/read May 5, 2016
http://businesswire.com/news/home/20091201005785/en January 1, 2015
http://htmlcorner.com/ptcbio.com March 3, 2016
http://biospace.com/news/eu-oks-mass-plant-for-genzyme-corporations-fabry/246620 May 5, 2016
http://afirma.com/physicians/latest-news/details February 2, 2016
http://aol.com/2013/02/27/genzyme-receives-company-award-from-european-organ July 7, 2017
http://businesswire.com/news/genzyme/20120120005363/en August 8, 2017
http://news.genzyme.com/press-release/fda-approves-genzymes-cerdelga-eliglustat-capsules May 5, 2015
http://news.genzyme.com/press-release/fda-grants-breakthrough-therapy-designation-genzymes-olipudase-alfa February 2, 2016
http://news.genzyme.com/press-release/european-chmp-adopts-positive-opinion-genzymes-cerdelga-eliglustat-capsules February 2, 2016
http://mediaroom.sanofi.com/sanofi-la-commission-europeenne-accorde-une-autorisation-de-mise-sur-le-marche-a-cerdelga-eliglustat-le-traitement-oral-de-genzyme-dans-la-maladie-de-gaucher-de-type-1-2 July 7, 2017
http://drugs.com/clinical_trials/two-year-data-phase-2-trial-genzyme-s-eliglustat-tartrate-gaucher-published-journal-blood-9968.html January 1, 2015
http://mediaroom.sanofi.com/sanofi-fda-grants-fast-track-designation-to-genzymes-investigational-substrate-reduction-therapy-for-the-treatment-of-fabry-disease-2 May 5, 2017
http://drugs.com/clinical_trials/two-year-data-phase-2-trial-genzyme-gaucher-oral-compound-suggest-continued-improvement-across-all-8856.html January 1, 2015
http://mediaroom.sanofi.com/sanofi-la-fda-accepte-levaluation-acceleree-de-la-therapie-experimentale-de-genzyme-par-reduction-de-substrat-pour-le-traitement-de-la-maladie-de-fabry-2 May 5, 2017
http://drugs.com/news/genzyme-begins-shipping-fabrazyme-newly-approved-framingham-manufacturing-plant-36756.html January 1, 2015
http://biospace.com/news_story.aspx April 4, 2016
http://phrma.org/news-media/related-resources/member-companies April 4, 2015
http://news.genzyme.com/press-release/genzyme-initiates-phase-12-clinical-trial-evaluate-olipudase-alfa-pediatric-patients February 2, 2016
http://aol.com/article/2013/09/19/sanofi-forms-partnership-with-umass-boston-with-1-/20724760 July 7, 2017
http://biospace.com/collaborative/News/sanofi-france-pays-700-million-for-12-percent-of/320732/Source=TopBreaking May 5, 2015
http://ptct.client.shareholder.com/releasedetail.cfm May 5, 2016
http://news.genzyme.com/press-release/genzyme-and-isis-present-kynamro-clinical-data-american-heart-association February 2, 2016
http://thenumbers.marketplace.org/publicradio/news/read/23556592/genzyme_receives_company_award_from_european_organisation_for_rare_diseases_ April 4, 2015
http://businesswire.com/news/genzyme/20110407005879/en September 9, 2017
http://drugs.com/news/fda-advisory-committee-recommends-randomized-trial-support-proposed-indication-clolar-adult-aml-19643.html February 2, 2015
http://drugs.com/news/genzyme-announces-accelerated-share-repurchase-25075.html January 1, 2015
http://businesswire.com/news/genzyme/20110710005114/en April 4, 2015
http://drugs.com/clinical_trials/genzyme-reports-clolar-data-further-supporting-potential-product-adult-aml-patients-6443.html April 4, 2015
http://news.sanofigenzyme.com/press-release/genzyme-phase-3-trial-campathfludara-combination-shows-potential-benefit-second-line-c February 2, 2017
http://news.sanofigenzyme.com/press-release/genzyme-reports-clolar-data-further-supporting-potential-product-treat-adult-aml-patie February 2, 2017
http://news.sanofigenzyme.com/press-release/sanofi-reports-positive-top-line-results-first-phase-3-study-alemtuzumab-lemtrada-mult February 2, 2017
http://news.sanofigenzyme.com/press-release/genzyme-announces-results-phase-3-trial-clolar-adult-aml February 2, 2017
http://news.sanofigenzyme.com/press-release/genzymes-mozobil-shows-promise-chemosensitization February 2, 2017
http://news.genzyme.com/press-release/sanofi-reports-positive-top-line-results-first-phase-3-study-alemtuzumab-lemtrada-mult February 2, 2016
http://news.genzyme.com/press-release/genzyme-reports-clolar-data-further-supporting-potential-product-treat-adult-aml-patie February 2, 2016
http://news.genzyme.com/press-release/genzymes-mozobil-shows-promise-chemosensitization February 2, 2016
http://drugs.com/clinical_trials/genzyme-s-campath-meets-primary-endpoint-phase-3-combination-therapy-trial-chronic-lymphocytic-8128.html April 4, 2015
http://drugs.com/clinical_trials/sanofi-reports-positive-top-line-results-first-phase-3-study-alemtuzumab-lemtrada-multiple-sclerosis-12098.html January 1, 2015
http://news.genzyme.com/press-release/genzyme-announces-results-phase-3-trial-clolar-adult-aml February 2, 2016
http://businesswire.com/news/genzyme/20110414006217/en January 1, 2015
http://cmscfoundation.org/2010/10/cmsc-and-fcmsc-award-first-neurosciencemultiple-sclerosis-scholarship-to-university-of-texas-health-science-center-student July 7, 2017
http://news.genzyme.com/press-release/genzyme-phase-3-trial-campathfludara-combination-shows-potential-benefit-second-line-c February 2, 2016
http://drugs.com/clinical_trials/significant-percentage-ms-patients-receiving-alemtuzumab-genzyme-s-phase-2-trial-remain-free-9154.html April 4, 2015
http://drugs.com/clinical_trials/genzyme-reports-clolar-data-further-supporting-potential-product-adult-aml-patients-6443.html January 1, 2015
http://news.sanofigenzyme.com/press-release/genzyme-reports-clolar-data-further-supporting-potential-product-treat-adult-aml-patie February 2, 2017
http://news.sanofigenzyme.com/press-release/study-results-multiple-sclerosis-patients-have-significant-and-sustained-reduction-dis February 2, 2017
http://news.sanofigenzyme.com/press-release/genzyme-announces-results-phase-3-trial-clolar-adult-aml February 2, 2017
http://drugs.com/news/genzyme-announces-fda-enforcement-action-regarding-allston-plant-23387.html April 4, 2015
http://news.genzyme.com/press-release/study-results-multiple-sclerosis-patients-have-significant-and-sustained-reduction-dis February 2, 2016
http://news.genzyme.com/press-release/genzyme-reports-clolar-data-further-supporting-potential-product-treat-adult-aml-patie February 2, 2016
http://drugs.com/clinical_trials/genzyme-s-campath-meets-primary-endpoint-phase-3-combination-therapy-trial-chronic-lymphocytic-8128.html April 4, 2015
http://news.genzyme.com/print/node/68 June 6, 2016
http://news.genzyme.com/press-release/genzyme-announces-results-phase-3-trial-clolar-adult-aml February 2, 2016
http://news.genzyme.com/press-release/genzyme-seeks-us-approval-clolar-treat-adult-aml February 2, 2016
http://news.sanofigenzyme.com/press-release/genzyme-seeks-us-approval-clolar-treat-adult-aml February 2, 2017
http://news.sanofigenzyme.com/print/node/68 February 2, 2017
http://drugs.com/clinical_trials/genzyme-announces-results-phase-3-trial-clolar-adult-aml-10424.html January 1, 2015

Please log in to uncover the email addresses, access the 372 results for genzyme.com, filters and more.

Create a free account

Already have an account? Sign in

More information about genzyme.com

Language of the website: English

Main technologies used:

Find email addresses from any website

Search contact information of any website in one click.

When you visit a website, click on the icon to find the email addresses related to the website.